Lv1
40 积分 2021-10-19 加入
Mantle cell lymphoma: how to clarify the confusion around first-line treatment?
1天前
待确认
Ibrutinib, Fludarabine, Cyclophosphamide and Obinutuzumab (iFCG) for Firstline Treatment of Patients with CLL with Mutated IGHV and without Del(17p)/ TP53 Mutation: Six-Year Follow-up Analyses
8个月前
已关闭
Chronic lymphocytic leukaemia
8个月前
已完结
Clinical pharmacology and PK/PD translation of the second-generation Bruton's tyrosine kinase inhibitor, zanubrutinib
3年前
已完结
皖公网安备34019202002308
